Novo Nordisk shares dip as latest prescription data points to GLP-1 pill slowdown
Novo Nordisk shares dip as latest prescription data points to GLP-1 pill slowdown
Novo Nordisk shares dip as latest prescription data points to GLP-1 pill slowdown
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.